Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma

Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

(2009) Kentaroh Yamamoto et al.   ANNALS OF SURGICAL ONCOLOGY

Treatment of Hepatocellular Carcinoma by Radioembolization Using 90Y Microspheres

(2009) Bruno Sangro et al.   DIGESTIVE DISEASES

FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma

(2009) Tatsuya Higashi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic Values of α-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma

(2009) Hyoung Su Kim et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival

(2009) Ahsun Riaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum  -Fetoprotein Response as a Surrogate for Clinical Outcome in Patients Receiving Systemic Therapy for Advanced Hepatocellular Carcinoma

(2009) S. R. Vora et al.   ONCOLOGIST

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis

(2008) Kwang-Hyub Han et al.   CANCER

Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors

(2008) Seung Up Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

(2008) Stephen L. Chan et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

(2008) Hidenori Toyoda et al.   JOURNAL OF HEPATOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE